PAMG
TEVA icon

Patton Albertson Miller Group’s Teva Pharmaceuticals TEVA Stock Holding History

Patton Albertson Miller Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-17,767
Closed -$892K – 132
2016
Q2 		$892K Sell
17,767
-9,218
-34% -$491K 0.4% 68
2016
Q1 		$1.44M Sell
26,985
-919
-3% -$53.9K 0.73% 47
2015
Q4 		$1.83M Sell
27,904
-37
-0.1% -$2.29K 0.92% 37
2015
Q3 		$1.58M Sell
27,941
-7,387
-21% -$479K 0.84% 42
2015
Q2 		$2.09M Sell
35,328
-12
-0% -$740 0.91% 48
2015
Q1 		$2.2M Buy
35,340
+6,075
+21% +$353K 0.89% 49
2014
Q4 		$1.68M Buy
29,265
+11,433
+64% +$637K 0.78% 48
2014
Q3 		$955K Buy
17,832
+7,581
+74% +$402K 0.5% 77
2014
Q2 		$542K Buy
10,251
+566
+6% +$28.9K 0.27% 111
2014
Q1 		$512K Sell
9,685
-1,935
-17% -$89.4K 0.27% 94
2013
Q4 		$466K Buy
11,620
+3,395
+41% +$134K 0.27% 88
2013
Q3 		$311K Buy
+8,225
New +$321K 0.18% 101

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Patton Albertson Miller Group's TEVA Position: Q3 2016 in Review

Patton Albertson Miller Group sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 17,767 shares — an estimated $892K sold.

Patton Albertson Miller Group first reported a position in TEVA in Q3 2013 and held it in 12 quarters. The position peaked at $2.2M in Q1 2015. 798 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

  • Patton Albertson Miller Group reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Patton Albertson Miller Group sold 17,767 Teva Pharmaceuticals shares in Q3 2016, an estimated $892K.
  • Patton Albertson Miller Group first reported a position in Teva Pharmaceuticals in Q3 2013 and held it in 12 quarters.
  • Patton Albertson Miller Group's Teva Pharmaceuticals position peaked at $2.2M in Q1 2015.
  • 798 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Patton Albertson Miller Group's 13F filing for Q3 2016, filed 10 Nov 2016.